Compare Novartis AG (NVS) vs Wheaton Precious Metals Corp (WPM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novartis AG vs Wheaton Precious Metals Corp — how do they compare? Novartis AG trades at $143.75 (market cap $268.57B), while Wheaton Precious Metals Corp trades at $138.65 (market cap $61.17B). The key difference: Novartis AG is far larger — about 4.4× Wheaton Precious Metals Corp's market cap, and Novartis AG pays the higher dividend (3.31%). Which is the better fit depends on your goals — on Pluang, investors hold Novartis AG for 82 Days and Wheaton Precious Metals Corp for 66 Days on average.
| NVS | WPM | |
|---|---|---|
Market Cap | $268.57B | $61.17B |
Volume | 1,532,573 | 1,092,361 |
Sector | Health | Basic Materials |
52-Week High | $168.62 | $165.72 |
52-Week Low | $121.80 | $94.37 |
Typical Hold Time | 82 Days | 66 Days |
Enterprise Value | $309.89B | $63.05B |
Dividend Yield | 3.31% | 0.58% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Novartis (NVS) trades at $143.11, down 0.12% with a bearish technical signal. The stock shows strong fundamentals with 24.67% net margin and $14B net income, though recent earnings were mixed with a Q1 miss. Analyst consensus is cautious with 68% hold ratings and a $146 target. Recent $7.8B licensing deal with China's Abogen highlights strategic moves amid pipeline setbacks.
Outlook remains balanced: valuation metrics appear reasonable (P/E 21.6) and profitability is robust, but clinical trial failures and investor scrutiny over M&A strategy pose risks. The stock trades near consensus target with institutional sentiment leaning neutral amid ongoing pipeline execution challenges.
Wheaton Precious Metals (WPM) trades at $134.96, up 0.95% today, with a bearish technical signal despite recent earnings beats. The company reported record 2025 revenue of $2.31 billion and net income of $1.47 billion, supported by strong profitability margins. Management targets 50% production growth by 2030 through streaming deals without new capital, as highlighted in recent investor events.
WPM presents a growth opportunity with a robust streaming model and fully funded pipeline, but faces risks from gold price volatility and high valuations. Analyst consensus is bullish with an $164.80 price target, though technical indicators suggest near-term caution. Upside depends on execution of expansion plans amid macroeconomic uncertainties.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Novartis AG
Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →About Wheaton Precious Metals Corp
Wheaton Precious Metals Corp is a precious metal streaming company. The company has entered into over 20 long-term purchase agreements with 17 different mining companies, for the purchase of precious metals and cobalt. It has streaming agreements covering approximately 19 operating mines and 9 development stage projects. The company's projects include Vale's Salobo mine and silver streams on Glencore's Antamina mine and Goldcorp's Penasquito mine.
Read more on WPM →
